Note
On June 1, 2019, DowDuPont Inc. (NYSE: DWDP) completed the spin-off of Corteva, Inc. (NYSE: CTVA). In addition, DowDuPont Inc. changed its name for DuPont de Nemours, Inc., and DuPont de Nemours, Inc.’s common shares also began trading on the New York Stock Exchange under the new ticker symbol “DD” on June 3, 2019. As such, investors in the market-linked GICs are hereby advised that only the common shares of DuPont de Nemours, Inc. (NYSE: DD) were included as Reference Shares in the Reference Portfolio for all calculations to be made under the market-linked GICs. On November 16, 2020, Pfizer Inc. (NYSE: PFE) (“Pfizer”) completed the transaction to spin-off its Upjohn division and combine it with Mylan N.V. (Nasdaq: MYL) to form Viatris Inc. (Nasdaq: VTRS) (“Viatris”), triggering a Potential Adjustment Event as per the terms and conditions of the market-linked GICs in respect of the common shares of Pfizer, a Reference Share in the Reference Portfolio of the market-linked GICs. As stockholders received common shares of Viatris, they were sold and reinvested in common shares of Pfizer. As a result, the Initial Value of the common shares of Pfizer was adjusted as of the closing of the markets on November 16, 2020.